Purcell & Lefkowitz LLP announced on May 5, 2025, that it is investigating Inhibikase Therapeutics, Inc. on behalf of the company's shareholders. The investigation seeks to determine whether Inhibikase Therapeutics' directors breached their fiduciary duties.
The investigation focuses on potential breaches of fiduciary duties in connection with recent corporate actions. Shareholders are encouraged to seek additional information about their rights and options.
This announcement indicates potential legal scrutiny regarding the company's governance and recent strategic decisions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.